Becton, Dickinson and Company (BDX)
NYSE
Closed
Aug 24, 2026
Day's Range
190.3652 wk Range
127.59Overview - BDX - Becton, Dickinson and Company
Key Statistics
Valuation
Enterprise Value
68.39B
P/E (Trailing)
‪33.21‬
P/E (Forward)
‪14.44‬
PEG Ratio
‪-1.05‬
Price / Sales (TTM)
‪2.32‬
Price / Book
‪2.14‬
EV / EBITDA
‪11.17‬
Profitability
Gross Margin
‪46.45%‬
Profit Margin
‪4.19%‬
Operating Margin
‪15.73%‬
Return on Assets
‪4.34%‬
Return on Equity
‪6.60%‬
Ownership
Shares Outstanding
272.38M
Float
271.64M
Short % of Shares Outstanding
‪4.19%‬
Held by Insiders
‪0.43%‬
Held by Institutions
‪99.60%‬
Price stats
Beta
‪0.25‬
50-Day Avg
‪161.40‬
200-Day Avg
‪157.66‬
Dividends
Payout Ratio
‪72.49%‬
Frequency
Quarterly
Analyst Consensus
14 analysts
Average price target
‪$ 194.42‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BDX - Becton, Dickinson and Company
Peers - BDX - Becton, Dickinson and Company
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - BDX - Becton, Dickinson and Company
About
Becton, Dickinson and Company is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare systems and research institutions worldwide. Its portfolio includes medical surgical products such as needles, syringes,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
